RespiroAI

Elevator Pitch: Imagine a world where COVID-19 and future pandemics can be quickly diagnosed with a simple CT scan analyzed by our AI, RespiroAI. Accessible anywhere, it’s not just saving time—it’s saving lives, leveraging cutting-edge AI for health equity.

Concept

AI-driven Diagnostic Tool for Rapid COVID-19 Detection Through CT Scans

Objective

To provide a fast, accurate, and accessible COVID-19 diagnostic solution using AI to analyze CT scans.

Solution

Leveraging 3D ResNet and Swin Transformer models for lung segmentation and COVID-19 detection from CT scans, enhanced by domain adaptation.

Revenue Model

Subscription-based for healthcare facilities and a pay-per-scan model for smaller clinics or emergency use.

Target Market

Hospitals, diagnostic centers, clinics globally, especially in areas with high COVID-19 prevalence or risk of future pandemics.

Expansion Plan

Extend capabilities to detect other respiratory diseases and integrate into telehealth platforms for remote diagnostics.

Potential Challenges

Data privacy concerns, accuracy maintenance across diverse populations, and ensuring system robustness.

Customer Problem

The need for rapid, reliable, and accessible COVID-19 diagnostics, especially in regions lacking specialized medical equipment or expertise.

Regulatory and Ethical Issues

Compliance with health data protection regulations (e.g., HIPAA, GDPR) and ensuring fairness in AI predictions.

Disruptiveness

Enormously reduces diagnostic time and improves access, transforming how respiratory illnesses are detected and managed.